NCT06154902Active, not recruiting
Real-World Outcomes in Relapsed/Refractory Multiple Myeloma Patients Treated, or Eligible for Treatment, With Idecabtagene Vicleucel
ABE-DESCART Study: Characterization and Outcomes of Patients With Relapsed and Refractory Multiple Myeloma Eligible for Treatment or Treated With Abecma© (Idecabtagene Vicleucel) in Real World Setting in France. A Database Analysis Based on the DESCAR-T Registry
Source: ClinicalTrials.gov · Last updated 4 Dec 2023
Brief summary (registry, in English)
The purpose of this study is to describe demographic and disease characteristics, treatment patterns, and clinical outcomes in the real-world setting among participants in France with relapsed/refractory multiple myeloma (RRMM) who are eligible for treatment with, or have been treated with, idecabtagene vicleucel. This study will use both prospective and retrospective data from the DESCAR-T registry database.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 350 (estimated)
- First submitted
- 27 Nov 2023
- Start date
- 29 Jul 2022
- Primary completion date
- 31 Jul 2027
- Lead sponsor
- Bristol-Myers Squibb
- Diseases
- Multiple myeloma, Childhood cancers
- NCT number
- NCT06154902
What you commit to
- Study type: Observational
- Planned participants: 350
- From 29 Jul 2022 to the primary completion date, 31 Jul 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Not registered with the social security in France
Who the study is looking for
- Patients with RRMM registered in the DESCAR-T registry and eligible for treatment or treated with idecabtagene vicleucel
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| DESCAR-T Registry Coordinator of this site? Confirm its status | Paris | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.